EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost‐Effectiveness Analysis of the Milan System for Reporting Salivary Gland Cytopathology in Fine‐Needle Aspiration Cytology of Salivary Gland Lesions

Louis Jansen iD, Lisa Nachtsheim, Sofia Kourou iD, Philipp Wolber, Kariem Sharaf, Kevin Hansen, Sami Shabli, Julia van de Loo, Alexander Quaas, Christoph Arolt, Marianne Engels, Lena Hieggelke und 3 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.71579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Louis Jansen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Salivary Glands, Cytodiagnosis. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Jean Uhrmacher Institute, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Salivary gland lesions (SGL) are a rare and heterogeneous group of benign and malignant masses. Fine‐needle aspiration cytology (FNAC), guided by the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC), offers a minimally invasive method for early differentiation of SGL. The purpose of this study was to evaluate the cost‐effectiveness of FNAC in diagnosing major SGL within the MSRSGC framework.

Methods

Three decision tree models were created based on probabilities from real‐world and literature data. Real‐world data was derived from the previously published largest single‐center study evaluating FNAC performance of SGL to date. Costs were determined from German and American fee catalogs. Multiple Monte Carlo simulations were run to assess the cost‐effectiveness of performing FNAC within the MSRSGC framework under different conditions for both health care systems.

Results

Using decision analysis, FNAC followed by surgery, if indicated, was less costly than upfront surgery. The cost reduction through FNAC was over 30% for all models. Cost reduction per case through FNAC followed by surgery, if indicated, compared to upfront surgery ranged between $5606 and $13,096 in the US model (average costs for upfront surgery: $17,472) and between 2465€ and 5337€ in the German model (average costs for upfront surgery: 8018€). When enhancing the German model with real world data, the cost reduction ranged between 2478€ and 5954€ (average costs for upfront surgery: 7988€).

Conclusion

In this model based on MSRSGC estimates and real‐world data, FNAC followed by surgery, if indicated, proved to be a more cost‐efficient approach to diagnosing SGL than upfront surgery. Thus, patients and healthcare systems benefit from high‐output centers that guarantee expert cytopathological diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsSalivary GlandsCytodiagnosisCost-Benefit AnalysisHumansBiopsy, Fine-NeedleCost-Effectiveness AnalysisDecision TreesMonte Carlo Method

Stichwörter der Autor:innen

fine needle aspiration cytologyhead and neck oncologyhealth economicssalivary gland cancersalivary gland tumor

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • University of Cologne, Institute for General Pathology and Pathologic Anatomy, Medical Faculty and University Hospital Cologne, Cologne, Germany.

ORCID-Profile: Louis Jansen, Sofia Kourou

Förderung

  • NCI NIH HHS
  • Jean Uhrmacher Institute
  • Deutsche Forschungsgemeinschaft
  • JuS-Foundation

Zitieren

APA

Jansen, L., Nachtsheim, L., Kourou, S., Wolber, P., Sharaf, K., Hansen, K., Shabli, S., van de Loo, J., Quaas, A., Arolt, C., Engels, M., Hieggelke, L., Morris, L. G. T., Klussmann, J. P., & Mayer, M. (2026). Cost‐Effectiveness Analysis of the Milan System for Reporting Salivary Gland Cytopathology in Fine‐Needle Aspiration Cytology of Salivary Gland Lesions. Cancer Medicine. https://doi.org/10.1002/cam4.71579

Vancouver

Jansen L, Nachtsheim L, Kourou S, Wolber P, Sharaf K, Hansen K, et al. Cost‐Effectiveness Analysis of the Milan System for Reporting Salivary Gland Cytopathology in Fine‐Needle Aspiration Cytology of Salivary Gland Lesions. Cancer Medicine. 2026. doi:10.1002/cam4.71579

BibTeX
@article{Jansen2026,
  author = {Jansen, Louis and Nachtsheim, Lisa and Kourou, Sofia and Wolber, Philipp and Sharaf, Kariem and Hansen, Kevin and Shabli, Sami and van de Loo, Julia and Quaas, Alexander and Arolt, Christoph and Engels, Marianne and Hieggelke, Lena and Morris, Luc G T and Klussmann, Jens Peter and Mayer, Marcel},
  title = {Cost‐Effectiveness Analysis of the Milan System for Reporting Salivary Gland Cytopathology in Fine‐Needle Aspiration Cytology of Salivary Gland Lesions},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71579}
}
Kostenlos starten →